A Study to Evaluate the Safety and Tolerability of AZD7442 in Chinese Adults

Clinical trial NCT05184062 · COMPLETED

Trial details

NCT number: NCT05184062
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Coronavirus Disease 2019 (COVID-19)

Start date: 2021-12-03
Primary completion: 2022-08-15
Enrollment: 272

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.